These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 31272306)

  • 1. Clinical characteristics of synthetic cannabinoid-induced psychotic disorders: a single-center analysis of hospitalized patients.
    Skryabin VY; Vinnikova MA
    J Addict Dis; 2018; 37(3-4):135-141. PubMed ID: 31272306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of synthetic cannabinoid-induced psychosis in relation to schizophrenia: a single-center cross-sectional analysis of concurrently hospitalized patients.
    Altintas M; Inanc L; Oruc GA; Arpacioglu S; Gulec H
    Neuropsychiatr Dis Treat; 2016; 12():1893-900. PubMed ID: 27536110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychotic Disorders in Patients Who Use Synthetic Cannabinoids.
    Skryabin VY; Vinnikova MA
    J Psychiatr Pract; 2019 Nov; 25(6):485-490. PubMed ID: 31821228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
    Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
    J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic and clinical characteristics of synthetic cannabinoid users in a large psychiatric emergency department in Turkey.
    Yalçın M; Tunalı N; Yıldız H; Oğuz A; Gültekin BK
    J Addict Dis; 2018; 37(3-4):259-267. PubMed ID: 31581902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
    Martinotti G; Santacroce R; Papanti D; Elgharably Y; Prilutskaya M; Corazza O
    CNS Neurol Disord Drug Targets; 2017; 16(5):567-575. PubMed ID: 28412921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Cannabinoid Use in a Psychiatric Patient Population: A Pilot Study.
    Welter S; Lücke C; Lam AP; Custal C; Moeller S; Sörös P; Thiel CM; Philipsen A; Müller HHO
    Eur Addict Res; 2017; 23(4):182-193. PubMed ID: 28848170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric symptoms and synthetic cannabinoid use: Information for clinicians.
    Sweet G; Kim S; Martin S; Washington NB; Brahm N
    Ment Health Clin; 2017 Jul; 7(4):156-159. PubMed ID: 29955515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New-Onset Prolonged Psychosis Following Synthetic Cannabinoid Use in an Older Patient: A Case Report.
    Alhassan A; Prahad SR; Burk BG; Fargason RE; Birur B
    Psychopharmacol Bull; 2024 Mar; 54(1):33-39. PubMed ID: 38449474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Synthetic Cannabinoid and Cannabis Users Admitted to a Psychiatric Hospital: A Comparative Study.
    Shalit N; Barzilay R; Shoval G; Shlosberg D; Mor N; Zweigenhaft N; Weizman A; Krivoy A
    J Clin Psychiatry; 2016 Aug; 77(8):e989-95. PubMed ID: 27379411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary psychosis with comorbid drug abuse and drug-induced psychosis: Diagnostic and clinical evolution at follow up.
    Mauri MC; Di Pace C; Reggiori A; Paletta S; Colasanti A
    Asian J Psychiatr; 2017 Oct; 29():117-122. PubMed ID: 29061407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of cough mixture abusers referred to three substance abuse clinics in Hong Kong: a retrospective study.
    Tang AK; Tang WK; Liang HJ; Chan F; Mak SC; Ungvari GS
    East Asian Arch Psychiatry; 2012 Dec; 22(4):154-9. PubMed ID: 23271584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosing psychotic disorders in the emergency department in the context of substance use.
    Schanzer BM; First MB; Dominguez B; Hasin DS; Caton CL
    Psychiatr Serv; 2006 Oct; 57(10):1468-73. PubMed ID: 17035567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic cannabinoid use: recognition and management.
    Castellanos D; Thornton G
    J Psychiatr Pract; 2012 Mar; 18(2):86-93. PubMed ID: 22418399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
    Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
    Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comorbidity of chronic somatic diseases in patients with psychotic disorders and their influence on 4-year outcomes of integrated care treatment (ACCESS II study).
    Lambert M; Ruppelt F; Siem AK; Rohenkohl AC; Kraft V; Luedecke D; Sengutta M; Schröter R; Daubmann A; Correll CU; Gallinat J; Karow A; Wiedemann K; Schöttle D
    Schizophr Res; 2018 Mar; 193():377-383. PubMed ID: 28778554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When acute-stage psychosis and substance use co-occur: differentiating substance-induced and primary psychotic disorders.
    Caton CL; Samet S; Hasin DS
    J Psychiatr Pract; 2000 Sep; 6(5):256-66. PubMed ID: 15990489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis and synthetic cannabinoids.
    Deng H; Verrico CD; Kosten TR; Nielsen DA
    Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of primary psychotic disorders with concurrent substance abuse and substance-induced psychotic disorders: A systematic review.
    Wilson L; Szigeti A; Kearney A; Clarke M
    Schizophr Res; 2018 Jul; 197():78-86. PubMed ID: 29117908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.